Atossa Therapeutics
ATOS
#9334
Rank
โ‚ฌ78.5 M
Marketcap
0,61ย โ‚ฌ
Share price
-13.37%
Change (1 day)
-40.30%
Change (1 year)

Atossa Therapeutics (ATOS) Fails to deliver data

Key failure to deliver metrics for Atossa Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Atossa Therapeutics (ATOS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Atossa Therapeutics (ATOS) - since 2018

Volume in USD (price x number of shares), data since 2018

Atossa Therapeutics (ATOS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ0.57 M-69.34%
2024โ‚ฌ1.86 M265.91%
2023โ‚ฌ0.5 M-93.57%
2022โ‚ฌ7.92 M-92.88%
2021โ‚ฌ0.11 B731.9%
2020โ‚ฌ13.37 M-10.09%
2019โ‚ฌ14.87 M138.47%
2018โ‚ฌ6.23 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
โ‚ฌ57.52 Mโ‚ฌ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ14.78 Mโ‚ฌ32.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ23.3 Mโ‚ฌ36.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
N/Aโ‚ฌ0.32 M๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ0.05 Mโ‚ฌ13.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚ฌ0.8 Mโ‚ฌ3.65 M๐Ÿ‡บ๐Ÿ‡ธ USA